SEC Form D private-offering filing

AirNexis Therapeutics, Inc.

Name: AirNexis Therapeutics, Inc. - new SEC Form D private-offering filing, Palo Alto, CA
Published: 2026-03-09

A new SEC Form D private-offering notice from Palo Alto, CA, a $200,000,000 filer-stated offering target in Biotech. The source filing is one click away.

AirNexis Therapeutics, Inc. site↗ Verified via SEC Form D

Clinical stage biotech developing AN01, a Phase 2 dual PDE3/4 inhibitor for chronic obstructive pulmonary disease (COPD).

Filed 2026-03-09Filed to raise $200,000,000First money in 2026-01-09Raised so far $62,000,000HQ (as filed) Palo Alto, CASector Biotech ✓Stage (inferred) LateCall status Delayed filing

Source linked the Form D on EDGAR↗Website verified airnexis.com↗Named in the filing 6 executives & directors

Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.